To explore whether FRAS1, FREM1 and FREM2 were involved in the process of immune infiltration in KIRC, we employed TIMER 2.0 to exhibit the landscape of FRAS1/FREM correlating with tumor purity and various immune infiltrates in human cancers. This evidence concerns the gene FREM1 and neoplasm.